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Abstract
Background: Superoxide dismutases (SODs) are important enzymes in defence against oxidative
stress. In Plasmodium falciparum, they may be expected to have special significance since part of the
parasite life cycle is spent in red blood cells where the formation of reactive oxygen species is likely
to be promoted by the products of haemoglobin breakdown. Thus, inhibitors of P. falciparum SODs
have potential as anti-malarial compounds. As a step towards their development we have
determined the crystal structure of the parasite's cytosolic iron superoxide dismutase.
Results:  The cytosolic iron superoxide dismutase from P. falciparum (PfFeSOD) has been
overexpressed in E. coli in a catalytically active form. Its crystal structure has been solved by
molecular replacement and refined against data extending to 2.5 Å resolution. The structure
reveals a two-domain organisation and an iron centre in which the metal is coordinated by three
histidines, an aspartate and a solvent molecule. Consistent with ultracentrifugation analysis the
enzyme is a dimer in which a hydrogen bonding lattice links the two active centres.
Conclusion: The tertiary structure of PfFeSOD is very similar to those of a number of other iron-
and manganese-dependent superoxide dismutases, moreover the active site residues are
conserved suggesting a common mechanism of action. Comparison of the dimer interfaces of
PfFeSOD with the human manganese-dependent superoxide dismutase reveals a number of
differences, which may underpin the design of parasite-selective superoxide dismutase inhibitors.
Background
Superoxide dismutases (SODs) are crucial enzymes in
both eukaryotes and prokaryotes. They catalyse the dis-
mutation of the superoxide radical to hydrogen peroxide
and dioxygen according to the two-step reaction as fol-
lows:
M3+ + O2 
.- → M2+ + O2
M2+ + O2 
.- + 2H+ → M3+ + H2O2
where M denotes a metal ion which interconverts between
oxidised and reduced states. The superoxide radical O2 
.- is
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formed in cells as a result of both enzymatic and sponta-
neous oxidation reactions. The superoxide radical is toxic
to living cells as it oxidises and degrades biological mole-
cules such as lipids and proteins [1].
For many years it was thought that malaria parasites had
no requirement for an endogenous superoxide dismutase
and merely exploited the activity of the host's enzyme in
the red blood cell [2]. However, in 1996 a Plasmodium fal-
ciparum iron-dependent SOD (PfFeSOD) was identified in
parasites isolated from infected blood cells [3]. Malaria
parasites are particularly prone to oxidative damage in the
intra-erythrocytic stage of their lifecycle. This is because an
important source of amino acids for the parasite is red
blood cell haemoglobin. Haemoglobin degradation pro-
duces free haem groups leading to oxidation of the iron
from the ferrous (Fe2+) to the ferric (Fe3+) state. This oxi-
dation liberates electrons, which promote the formation
of reactive oxygen intermediates, including superoxide.
The PfFeSOD gene is expressed at its highest level during
this stage of the parasite life cycle [4].
SODs are classified according to their metal cofactors.
Eukaryotic cells are generally served by a cytosolic Cu/
ZnSOD and an evolutionarily unrelated mitochondrial
MnSOD. Some eukaryotes also contain a SOD containing
a single Fe atom. Bacterial cells feature single metal-cen-
tred SODs in which the metal can be either manganese or
iron. The FeSODs and the MnSODs exhibit recognisable
similarities in their sequences, they have a common α/β
tertiary structure and they use the same residues to coordi-
nate the metal [5]. These are quite distinct from the two-
metal Cu/ZnSODs, which have a Greek key β-barrel fold
[6]. The MnSODs of eukaryotic origin are distinguishable
from those of prokaryotic sources on the basis of their
quaternary structure; the former are tetramers while the
latter are dimers. Small sequence differences distinguish
the Mn- and FeSODs [7]. Biochemically, FeSODs are more
sensitive to inhibition by azide [8] and have a greater sus-
ceptibility to inactivation by hydrogen peroxide, than
MnSODs. Iron and manganese superoxide dismutases can
bind either metal cofactor. However, most are only func-
tional with their cognate metal co-factor bound. Some
enzymes however, maintain activity with either Fe or Mn
bound and are termed cambialistic [9].
In 2002, an electron paramagnetic resonance and model-
ling study of SOD from P. falciparum showed it was, as
expected, an iron-dependent dimer [10]. The fact that it is
an FeSOD and distinct from human tetrameric Mn and
Cu/ZnSODs raises the possibility of its exploitation as an
anti-malarial drug target [11] and indeed inhibitors of
PfFeSOD have been identified [12]. This study presents an
X-ray crystal structure of P. falciparum FeSOD solved at a
resolution of 2.5 Å.
Results
Protein characterization
Purified PfFeSOD was resolved by electrophoresis for 3
hours at 100 V in a 10% native polyacrylamide gel. The gel
was soaked in riboflavin and NADPH to generate superox-
ide radicals, and stained by Nitro Blue Tetrazolium (NBT)
dye. NBT reacts with superoxide to form a blue precipitate
when fixed in a gel. Any regions on the gel that exhibit
SOD activity will therefore be white against a blue back-
ground. A clear white band coincident with the PfFeSOD
protein indicated that the protein was active. Analytical
ultracentrifugation (AUC) sedimentation equilibrium
experiments estimated the molecular weight of the pro-
tein to be 47,400 ± 700 Da. Since the calculated molecular
weight of the monomer is 23,799 Da, this indicates that
PfFeSOD is a dimer, consistent with previously character-
ised FeSODs, which are either dimers or tetramers.
Overall structure
The crystal structure of PfFeSOD has been solved and
refined against data extending to 2.5 Å spacing. The
refined model consists of two polypeptide chains, A and
B, which are related by a non-crystallographic two-fold
axis of symmetry, together with two iron ions and 140 sol-
vent water molecules. The electron density maps are con-
tiguous from residue 1 to residue 197 of both chains. The
C-terminal PfFeSOD residue (Lys198), together with the
eight residues of the C-terminal tag are not observed in the
electron density maps. Details of the refinement statistics
are given in Table 1. There is a solitary outlier in the Ram-
achandran plot at residue Lys43 in the B chain, which
occurs in a partially ordered surface loop. The Ser15-Pro16
peptide bond in both chains is in the cis conformation.
The overall structure is similar to those of previously
solved iron superoxide dismutases, consisting of an
amino terminal α-helical domain linked to a carboxy ter-
minal  α/β domain. The first eleven residues have an
extended structure and are involved in crystal packing.
The next 70 residues form two long anti-parallel α-helices
(α1 and α3) connected by a meandering loop containing
a third helix, α2. In both subunits, helix α1 has a noticea-
ble kink at the conserved Lys29 residue, a feature that has
been noted before [13]. This domain is connected via an
extended loop to the α/β domain (Figure 2A), which com-
prises a three-stranded anti-parallel β-pleated sheet
(strand order β3-β1-β2) surrounded by four α-helices.
Superposition of equivalent Cα atoms of chain A and
chain B of PfFeSOD gives a positional root mean squared
deviation (rmsΔ) of 0.3 Å. The PfFeSOD structure super-
poses onto the molecular replacement model, E. coli
FeSOD, with an rmsΔ of 0.55 Å over all equivalent Cα
atoms.BMC Structural Biology 2006, 6:20 http://www.biomedcentral.com/1472-6807/6/20
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Structural comparisons and dimer interface
The tertiary structure is very similar to that of a number of
other Fe- or Mn-dependent SOD enzymes. Of particular
interest is comparison with the tetrameric MnSOD found
in human mitochondria. Subtle differences in the struc-
tures may allow the design of inhibitors to block the activ-
ity of FeSOD selectively without affecting the MnSOD.
The arrangement of the active site residues is well con-
served between the Fe and MnSODs; the only significant
difference in main chain conformation arises in the loop
connecting α1 and α3, which is remote from the active
site and the dimer interface.
As is typical of SOD proteins, only a relatively small acces-
sible surface area (9.7 %) becomes buried in the dimer
interface. The main contributions to the dimer interface
arise from helix α1, the loop that connects α5 to β1 and
the loop connecting β3 to α6. 41% of the atoms forming
the dimer interface are polar, while 59% are non-polar.
There are five bridging water molecules within the dimer
interface. There is an interesting pair of adjacent charge-
charge interactions between the carboxylates of the Asp140
residues and the side chain imidazoles of His139. Perhaps
associated with this, the dihedral angles of residue Asp140
appear in a generously allowed location on the Ramach-
andran plot. These residues lie on what would be a classi-
cal β-turn were it not for the fact that residue 141 is an
alanine rather than a glycine. All of the dimer stabilising
interactions in the E. coli enzyme are conserved in
PfFeSOD. Such high conservation of the dimer interface
reflects the importance of dimerisation to the activity of
dismutases.
Active site of P. falciparum FeSOD
The metal ion in both subunits of the enzyme is five-coor-
dinate. Three bonds arise from coordination with histi-
dine Nε2 atoms of residues His26 (mean Fe-Nε2 distance
2.2 Å), His73 (2.1 Å) and His161 (2.0 Å). A further bond is
between the metal and the Oδ2 atom of Asp157 (mean Fe-
Oδ2 distance 1.9 Å). The fifth coordination position is an
oxygen atom from either a water molecule or a hydroxide
species (mean Fe-O distance 2.1 Å). The coordination
Table 1: Data collection and refinement statistics
PfFeSod (PDB code 2BPI)
Data collection
X-ray source ESRF Beamline ID29
Wavelength (Å) 0.976000
Collection Temperature (K) 100
Resolution range (Å) 25.00 – 2.52
Space group P212121
Unit-cell parameters (Å) a = 55.94, b = 78.91, c = 90.62
Matthews coefficient/solvent content (%) 2.2/43.0
Number of unique reflections, overall/outer shella 13247 (843)
Completeness (%), overall/outer shella 98.8 (100)
Redundancy, overall/outer shella 4.1 (4.2)
I/σ(I), overall/outer shella 17.3 (6.2)
Rmerge
b (%), overall/outer shella 8.3 (29.7)
Refinement and model statistics
R-factorc 0.187 (0.224)
R-freed 0.263 (0.338)
Molecules/asymmetric unit 2
Number of protein non hydrogen atoms 3345
Number of water molecules 140
Rms deviation from targete
Bond lengths (Å) 0.014
Bond angles (°) 1.453
Average B-factor (Å2)2 8 . 1 0
Ramachandran plotf 90.3/8.6/0.6/0.6
a Figures in parentheses concern the outer shell and corresponds to 2.582–2.520 Å.
b Rmerge = Σhkl Σi|Ii - <I> |/Σhkl Σi <I> where Ii is the intensity of the ith measurement of a reflection with indexes hkl and <I> is the statistically weighted 
average reflection intensity.
c R-factor = Σ ||Fo| - |Fc||/Σ |Fo| where Fo and Fc are the observed and calculated structure factor amplitudes, respectively.
d R-free is the R-factor calculated with 5 % of the reflections chosen at random and omitted from refinement.
e Root-mean-square deviation of bond lengths or bond angles from ideal geometry.
f Percentage of residues in most favoured/additionally allowed/generously allowed/disallowed regions of the Ramachandran plot, according to 
PROCHECK.BMC Structural Biology 2006, 6:20 http://www.biomedcentral.com/1472-6807/6/20
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geometry is trigonal bipyramidal, with His73, His161 and
Asp157 providing the equatorial ligands and with His26
and the hydroxide or water oxygen atom forming the axial
ligands.
The area around the active site is fairly hydrophobic with
two tryptophan residues (122 and 159) 5.4 Å and 6.1 Å
from the metal, respectively. Trp122 forms a hydrogen
bond to Gln69, which in turn forms a hydrogen bond with
the hydroxyl group of Tyr34. Tyr34  is also hydrogen
bonded via a water molecule to His30, which is bonded to
Tyr134 from the other subunit. This classical hydrogen-
bonding network in superoxide dismutases may allow
communication between the two metal sites [13]. In the B
chain however, we note that the Gln69 Nδ to Tyr34 -OH
distance is longer (3.6 Å), perhaps due to coordinate error
at this resolution. The spatial arrangement of the residues
in the active site is otherwise identical to those of other Fe-
dependent superoxide dismutases whose structures are
known, consistent with the notion that structure and
mechanism are highly conserved in this enzyme class.
A second line of communication between the active sites
is afforded by the intermolecular ionic/hydrogen bonding
interaction between the Fe-coordinating His161 and the
carboxylate of Glu160. The latter is situated in a loop that
links two Fe-coordinating residues (Asp157 and His161) in
the opposing subunit. The relevance, if any, of structural
communication between the active sites to the kinetics
and mechanism of these enzymes is not established.
Modelling of the P. falciparum mitochondrially targeted 
FeSOD
The sequence of the major FeSOD is highly conserved in
different Plasmodia species (see Additional file 2) and is
encoded by a gene on chromosome 8 (PlasmoDB code
PF08_0071 [14]) consisting of a single exon. Another
gene product (PfFeSOD2) with significant sequence
homology is located on chromosome 6. This PfFeSOD2
gene is interrupted with multiple introns. The original
gene model (MAL6P1.194 [14]) was revised by a bioinfor-
matic analysis to maximise primary sequence homology
to PfFeSOD, leading to a gene predicted to consist of nine
exons, separated by eight introns with consensus splice
donor/acceptor sites (see Additional file 3). Evidence sup-
porting the model was found by Plasmodium interspecies
conservation of the intron-exon structure, which is a good
predictor for small exons [15] and subsequently con-
firmed by cDNA cloning [16]. A striking feature of the
PfFeSOD2 gene is that it encodes an N-terminal sequence
typical of proteins that are targeted to sub-cellular
organelles. The first two exons coincide precisely with ele-
Sequence alignment of FeSOD from P. falciparum and E.coli and MnSOD from the human mitochondrion Figure 1
Sequence alignment of FeSOD from P. falciparum and E.coli and MnSOD from the human mitochondrion. Identical residues are 
highlighted with a red background and similar residues are boxed. PfFeSOD (top) and MnSOD (PDB code 1n0j [36] bottom) 
secondary structure elements are indicated. Residues predicted to be specific to MnSOD sequences [37] are marked with a 
triangle. Note the similarity of secondary structure between the two types of SOD. The longer helices in the N-terminal 
domain of MnSOD contribute to tetramer formation. The figure was made using ESPript [38].BMC Structural Biology 2006, 6:20 http://www.biomedcentral.com/1472-6807/6/20
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ments of the bipartite signal (see Additional file 4) namely
a signal sequence and a transit peptide. A GFP-fusion with
the signal is directed to the mitochondrion, despite pre-
dictions from the sequence that it would be delivered to
the apicoplast [16]. However, the gene structure not only
hints at its evolution by exon shuffling, but provides the
opportunity for alternatively spliced forms [17].
A homology model (see Additional file 1) of the mito-
chondrially targeted PfFeSOD2 was derived using the
cytosolic PfFeSOD structure solved here. The cytosolic
PfFeSOD is the closest in sequence of any dismutase to the
mitochondrial PfFeSOD and hence provides the most
suitable coordinate set from which to construct a homol-
ogy model. The model generated has an rmsΔ on all Cα
atoms of 0.36 Å for the 388 matched residues. Unsurpris-
ingly the secondary structure is predicted to be identical to
that of the cytosolic FeSOD of Plasmodium. It appears
that the active site and dimer interface are also well con-
served. This is consistent across the Fe/MnSOD enzyme
family, which is a highly conserved enzyme class. It
remains to be seen if the two superoxide dismutases from
Plasmodium are indeed structurally and biochemically
equivalent, or whether the mitochondrially targeted SOD
has a different turnover/stability that is required for func-
tion within a specific environment in the cell.
Discussion
Superoxide dismutases play a crucial role in the chemical
protection strategies many cells adopt to counter the con-
siderable threat posed by the superoxide anion radical.
Iron-containing superoxide dismutases are essentially
confined to prokaryotes, algae, higher plants and certain
protozoa [12]. In contrast, the human superoxide dis-
mutases are either Mn- or Cu/Zn-dependent. Thus, selec-
tive inhibitors of FeSODs have potential uses in therapy
against diseases caused by pathogens. At first sight it
would appear difficult to inhibit PfFeSOD using classical
'active-site directed' approaches. The substrate-binding
site is small, it needs to accommodate just two atoms and
the design of selective inhibitors may be hampered by the
structural similarity that the iron-containing superoxide
dismutases share with the manganese-dependent
enzymes. Superoxide is attracted to the active site of dis-
mutases through a funnel, which comprises residues from
both subunits in the dimer. The funnel lies at the top of
A) Ribbon representation of PfFeSOD polypeptide chain with colour ramping from the amino terminus in red to the carboxyl  terminus in magenta Figure 2
A) Ribbon representation of PfFeSOD polypeptide chain with colour ramping from the amino terminus in red to the carboxyl 
terminus in magenta. The iron is shown as a red sphere and its coordinating residues His26, His73, Asp157 and His161 are shown 
in cylinder representation. B) The PfFeSOD dimer coloured by subunit with the Fe atoms as mauve spheres and their coordi-
nating residues in cylinder representation. The figures were made using CCP4 mg [39].
α α α α1
α α α α2
α α α α3
α α α α7
α α α α4
α α α α5
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the dimer interface near to the metal sites. It is thought
that potential inhibitors could bind here and block access
to the active site for the superoxide substrate [13].
An alternative approach is to target inhibitors towards the
subunit interface so as to disrupt the quaternary structure.
A possible explanation of the widely accepted "ping-
pong" kinetics observed for FeSODs would be if superox-
ide binding in one active site is accompanied by oxidation
to oxygen in the other, with the iron atoms in the respec-
tive subunits maintaining opposing oxidation states as
they alternate between the +2 and +3 forms. If so, dimeri-
sation would likely be important to the mechanism of
FeSOD, and monomeric FeSODs are not found in Nature
[13]. However, evidence from Cu/ZnSODs suggests that
monomeric forms are active which may mean that dimer-
isation is not crucial for the function of all superoxide dis-
mutases [18]. Despite this, it is clear that the dimer
interface in Fe and MnSODs is important in the SOD reac-
tion with dimer interface mutants of human MnSOD
exhibiting reduced steady-state catalytic constants
[19,20]. Other evidence points to the importance of dim-
erisation for functional SOD activity, as dimer destabilis-
ing mutations of Cu/Zn SOD have been linked to motor
neuron disease [21]. Although the mechanism is unclear,
the destabilised mutants may be more prone to aggrega-
tion, which is commonly associated with the disease.
There are a number of significant differences between the
dimer interfaces in PfFeSOD and HuMnSOD that may be
exploited in the design of parasite selective inhibitors.
Residue Phe118, which contributes 15 % of the accessible
surface area buried in the interface in PfFeSOD is replaced
with glutamine in the human enzyme. The intermolecular
polar/salt-bridging residue pair of His139 and Asp140 in
PfFeSOD is substituted by Cys and Pro, respectively in
The active site from one subunit of the FeSOD dimer Figure 3
The active site from one subunit of the FeSOD dimer. The metal is shown as a grey sphere and the water molecule that acts as 
an axial ligand to the metal is coloured red. The 2Fo-Fc electron density map, contoured at the one sigma level, is represented 
as a mesh.BMC Structural Biology 2006, 6:20 http://www.biomedcentral.com/1472-6807/6/20
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HuMnSOD, similarly the Glu21-Arg168  ion pair in
PfFeSOD appears as Ala and Lys respectively in the human
enzyme. These differences ought to be exploitable in the
selective design of dimer-disrupting mutants.
Inhibitors of PfFeSOD have already been identified from
a random screening of a chemical library of compounds
[12]. A subset of these uncharged polyaromatic com-
pounds, with molecular weights in the range 200–700 Da,
have in vitro anti-malarial activity, with IC50 values in the
micromolar range. Their mechanism of action and their
selectivity was not determined so it remains to be seen
whether they interfere with dimer formation. A number of
small molecule inhibitors of protein-protein interactions
with biomedical significance have been reported recently
[22]. For Trypanosoma cruzi, a parasite-selective inhibitor
of triosephosphate isomerase has been identified and
shown to act by blocking dimerisation [23], so it appears
that the strategy could be useful, particularly as the per-
centage of accessible protein surface that becomes buried
in a SOD dimer is at the lower limit of the range normally
seen in protein multimers in Nature.
Conclusion
The X-ray structure of P. falciparum SOD provides the
detailed template on which comparisons with human
enzyme can be made, and for the design of potential par-
asite-specific inhibitors. In particular, the biochemical
properties of the SOD enzyme (and differences to the
human SOD protein) suggest that a possible mode of
inhibition would be to disrupt the dimer interface that
may be important to its function and stability. The intra-
erythocytic stages of the parasite are in an environment
that is known to be rich in antioxidant defences (both
chemical and enzymatic) that might compensate an
inhibitory effect. However, the selective delivery of inhib-
itors to the parasite organellar system may prove to be a
useful route to new therapeutics.
Methods
Cloning and expression of P. falciparum FeSOD
The cytosolic FeSOD coding sequence was amplified from
P. falciparum (3D7) genomic DNA using Vent™ polymer-
ase (New England Biolabs) and the oligonucleotide prim-
ers:
5'-CATGCCATGGTTATTACATTGCCCAAATTAAAG-3'
5'-CCGCTCGAGCTTTTGCATAGCTTTTTTTAAGTT-3'.
The 597 base pair PCR product was digested with NcoI
and XhoI and ligated to similarly cut pET28a (Novagen).
This places the coding sequence for PfFeSOD upstream of
that for a non-cleavable, C-terminal His6 tag. The expected
expression product therefore comprises residues 1–198 of
PfFeSOD with a C-terminal LEHHHHHH tag. The ligation
products were introduced into competent E. coli NovaB-
lue™ cells (Novagen). Kanamycin-resistant transformants
harbouring pET28-PfFeSOD were identified and isolated.
Plasmid DNA from these cells was purified and subse-
quently introduced into the expression strain E. coli BL21-
CodonPlus (Stratagene). An overnight culture of E. coli
BL21/pET28-PfFeSOD was used to inoculate 1 litre of
Luria-Bertani medium supplemented with 30μg ml-1 kan-
amycin and cells were grown with shaking at 37°C to an
OD600 of 0.6 at which point expression of recombinant
protein was induced by the addition of isopropyl-β, D-thi-
ogalactopyranoside to a final concentration of 1 mM.
After a further 4 hours incubation at 30°C, cells were har-
vested by centrifugation.
Purification, characterisation and crystallisation
The harvested cell pellet was resuspended in 50 mM Tris-
HCl buffer pH 7.5 containing 300 mM NaCl (Buffer A).
The cells were lysed by sonication and clarified by centrif-
ugation. The supernatant was mixed with 2 ml Ni-NTA
agarose resin (Qiagen) at 4°C for 1 hour with gentle shak-
ing. The resin was then washed with Buffer A containing
20 mM imidazole and protein was eluted with Buffer A
containing 100 mM imidazole. Fractions were examined
by Coomassie staining following SDS-polyacrylamide gel
electrophoresis and those containing proteins of approxi-
mately 23 kDa corresponding to FeSOD were pooled and
further fractionated by size exclusion chromatography on
a Superdex 75 (Pharmacia) column run in 50 mM Tris-
HCl pH 7.5 containing 100 mM NaCl. Typically 10 – 15
mg of protein was obtained per litre of cell culture.
Sedimentation equilibrium experiments were conducted
on a Beckman Optima XL/I analytical ultracentrifuge, in
an AN-50Ti rotor. The buffer density (300 mM NaCl, 50
mM Tris-HCl, pH 7.5) and the partial specific volume of
the protein were estimated to be 1.012 g.ml-1 and 0.7302
respectively, using the program SEDNTERP [24]. Protein
homogeneity was examined on an 8.75 % native polyacr-
ylamide gel. Enzyme activity was confirmed using a gel-
based Nitro blue tetrazolium assay [25].
Crystallisation experiments were carried out by the hang-
ing-drop vapour-diffusion method. Drops contained a 1:1
volume ratio of PfSOD at 10 mg ml-1 in 50 mM Tris-HCl
pH 7.5, 100 mM NaCl and a range of precipitants. Rod
shaped crystals appeared within a week at 18°C from res-
ervoir solutions that contained 0.1 M Tris-HCl pH 7.5 and
30–40% (w/v) polyethylene glycol (PEG) 600.
Data collection
Crystals were mounted in a fine rayon loop and trans-
ferred into a solution containing 0.1 M Tris-HCl (pH 7.5)
and 40 % PEG 600 which acts as a cryoprotectant. TheyBMC Structural Biology 2006, 6:20 http://www.biomedcentral.com/1472-6807/6/20
Page 8 of 10
(page number not for citation purposes)
were then flash-cooled in liquid nitrogen. Preliminary in-
house X-ray analysis of these crystals showed that they
belong to the space group P212121 with unit cell dimen-
sions a = 55.5 Å, b = 78.4 Å, c = 89.3 Å. A complete X-ray
diffraction data set was collected at 100 K, using synchro-
tron radiation at a wavelength of 0.976 Å, on beamline
ID-29 at the ESRF, Grenoble, using an ADSC Quantum4
CCD detector. The data were processed using the pro-
grams DENZO and SCALEPACK [26].
Structure determination and refinement
Calculations were performed using the CCP4 suite of pro-
grams [27]. Molecular replacement was performed with
AMoRe  [28] and refinement conducted with REFMAC
[29]. The structure was determined by the molecular
replacement method using the Escherichia coli FeSOD
coordinate set (PDB entry code 1ISC) as a search model.
EcSOD and PfSOD share 51% sequence identity. Molecu-
lar replacement calculations produced two clear solutions
related by a non-crystallographic 2-fold symmetry axis,
and giving an R-factor of 40.4 % after rigid body refine-
ment. Model building was performed using the X-
AUTOFIT  routines [30] implemented in the molecular
graphics programme QUANTA  (Accelrys, San Diego).
During refinement, tight non-crystallographic symmetry
restraints were imposed on the main chain atoms and
medium restraints on the side chains of the two molecules
in the dimer.
Modelling the targeted SOD
A homology model of the mitochondrial FeSOD
(PfFeSOD2) was generated on the basis of 52% sequence
identity over 188 residues to the known structure of the
cytosolic PfFeSOD. All structural visualisation/manipula-
tion was performed using QUANTA. The sequences of
PfFeSOD2 and the PfFeSOD template structure were
aligned using CLUSTALX [31], and manually corrected for
certain regions, based on interrogation of the known
structure.
Homology modelling was performed using MODELLER6
[32]. Ten initial models were generated, and the model
with the lowest objective function chosen as the repre-
sentative PfFeSOD2 structure. After manual checking of
backbone and side chain positions, energy minimization
was performed using CHARMM [33,34] to relax steric
clashes within the model. Stereochemical evaluation was
then performed using PROCHECK [35]. The model pos-
sesses good stereochemical quality, with 88.4 % of resi-
dues in the most favoured regions of the Ramachandran
map, and 10.4 % in additional allowed regions. There are
four residues in generously allowed or unfavourable
regions, which accurately reflect those in the template
structure.
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Additional material
Additional File 1
Model of the P. falciparum mitochondrially targeted FeSOD2. Data file 
PfSOD2_model.pdb.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1472-
6807-6-20-S1.pdb]
Additional File 2
Sequence alignment of Plasmodia FeSOD sequences. FeSOD is one the 
most highly conserved proteins across different Plasmodium species [40]. 
Identical residues are highlighted with a red background and similar res-
idues are boxed. PfFeSOD secondary structure elements are superposed. 
Codes: Pf, P. falciparum; Pr, P. reichenowi; Po, P. ovalae; Pm, P. 
malariae; Pv, P. vivax; Pk, P. knowlesi; Py, P. yeolii; Pb, P. berghei; 
Pc, P. chabaudi; Pg, P. gallinaceum. The figure was made using ESPript 
[38].
Click here for file
[http://www.biomedcentral.com/content/supplementary/1472-
6807-6-20-S2.ppt]
Additional File 3
Gene model of PfFeSOD2. A region of DNA sequence from P. falci-
parum chromosome 6 is shown, with predicted introns highlighted in yel-
low, and the protein product of the exon sequences in red.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1472-
6807-6-20-S3.pdf]
Additional File 4
Sequence alignment of predicted PfFeSOD2 proteins from Plasmodium 
species. Identical residues are highlighted with a red background and sim-
ilar residues are boxed. PfFeSOD2 predicted secondary structure elements 
are superposed and exon boundaries are marked with a triangle. Note that 
the first two exons coincide with the putative signal sequence and transit 
peptide. Sequence data were gleaned from PlasmoDB [14]. Although not 
shown, the incomplete sequence data from P. chabaudi (missing region 
around exons 4 & 5) and P. gallinaceum (missing region encompassing 
6 & 7) also show the same conserved pattern of putative intron bounda-
ries. Codes: Pf, P. falciparum; Pr, P. reichenowi; Pv, P. vivax; Pk, P. 
knowlesi; Pb, P. berghei; Py, P. yeolii.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1472-
6807-6-20-S4.ppt]BMC Structural Biology 2006, 6:20 http://www.biomedcentral.com/1472-6807/6/20
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